Heath Ledger's Legacy For Drug Marketers

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

The death of Heath Ledger may have a silver lining for drug marketers: The public may finally pay attention to their efforts to dissuade consumers from abusing OTC and prescription medicines.

Medicine abuse is a difficult issue for drug marketers. Most brands rely on “safety” as a distinct part of their equity. Drawing attention to the fact that some people use them in unsafe ways risks contaminating that equity, even if the intent is to safeguard consumers’ health.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in